Home‐based contact immunotherapy with diphenylcyclopropenone for alopecia areata is as effective and safe as clinic‐based treatment in patients with stable disease: A retrospective study of 40 patients
Sign Up to like & getrecommendations! Published in 2018 at "Journal of the American Academy of Dermatology"
DOI: 10.1016/j.jaad.2017.09.037
Abstract: context of appropriate and essential medical care, the treatment of AA satisfies the definition of medical necessity and is merited, by objective measures, in the same way that treatment of other chronic dermatoses, such as… read more here.
Keywords: contact immunotherapy; diphenylcyclopropenone alopecia; home based; treatment ... See more keywords
Diphenylcyclopropenone for alopecia areata: a U.K. survey
Sign Up to like & getrecommendations! Published in 2018 at "British Journal of Dermatology"
DOI: 10.1111/bjd.16489
Abstract: Alopecia areata (AA) is a T-cell mediated autoimmune hair loss condition with an estimated lifetime risk of 1.7%. It is characterized clinically by sudden-onset non-inflammatory hair loss that may occur at any site. The disease… read more here.
Keywords: alopecia areata; hair loss; diphenylcyclopropenone alopecia; alopecia ... See more keywords